A recent study indicates that people who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who halt traditional diet and exercise programs.
Published data in a prominent medical journal demonstrates that while overweight individuals often shed about a fifth of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"Users buying these medications need to be informed of the risk of quick rebound weight gain when the medication concludes," warns lead investigator Dr. Susan Jebb.
This pace of regain suggests a reversion to starting mass within about a year and a half.
Weighing Therapies
The research, which looked at 37 of studies involving thousands of patients, compared the effects of the injectable medications with older methods.
Researchers emphasize that individuals who shed pounds through dieting typically see a slower creep back—approximately 0.1 kg a month—post-intervention.
The Reason for the Fast Rebound
Experts suggest the way of the drugs accounts for the amplified rebound.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Artificially providing the hormone concentrations several times higher than normal could lead to the body to generate a reduced amount of its endogenous hormone, and could diminish responsiveness to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this GLP-1 'fix' leads to appetite is no longer kept in check, making excessive eating a significant risk."
A Chronic Condition?
Medical guidelines advise the injections for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians say that, given the likelihood of relapse, the treatment should be considered ongoing.
This perspective is reinforced by pharmaceutical companies, who state that the findings "emphasize the chronic character of obesity," similar to managing diseases like hypertension.
User Accounts
People who have stopped the medication explain a powerful return of hunger.
"It felt as if something that goes on and I was suddenly starving," recalled one woman.
The struggle is worsened if users have not established permanent dietary or behavioural modifications during treatment.
Growing Use
Figures show that a significant number of adults in the UK have used these injections in the last 12 months, with desire being substantial.
- Adoption is higher among women compared to men.
- The middle-aged age group shows the highest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
Ultimately, researchers caution that while these medications are powerful agents for weight loss, they are not a standalone solution and long-term success likely depends on integrated lifestyle support.
